153 related articles for article (PubMed ID: 1314525)
1. Suxamethonium block in the myasthenic patient. Correlation with plasma cholinesterase.
Baraka A
Anaesthesia; 1992 Mar; 47(3):217-9. PubMed ID: 1314525
[TBL] [Abstract][Full Text] [Related]
2. Repeated doses of suxamethonium in the myasthenic patient.
Baraka A; Baroody M; Yazbeck V
Anaesthesia; 1993 Sep; 48(9):782-4. PubMed ID: 8214497
[TBL] [Abstract][Full Text] [Related]
3. Neuromuscular effects of halothane, suxamethonium and tubocurarine in a myasthenic undergoing thymectomy.
Baraka A; Afifi A; Muallem M; Kachachi T; Frayha F
Br J Anaesth; 1971 Jan; 43(1):91-5. PubMed ID: 4324539
[No Abstract] [Full Text] [Related]
4. Response to suxamethonium in a myasthenic patient during remission.
Abel M; Eisenkraft JB; Patel N
Anaesthesia; 1991 Jan; 46(1):30-2. PubMed ID: 1996750
[TBL] [Abstract][Full Text] [Related]
5. Vecuronium block in the myasthenic patient. Influence of anticholinesterase therapy.
Baraka A; Taha S; Yazbeck V; Rizkallah P
Anaesthesia; 1993 Jul; 48(7):588-90. PubMed ID: 8102223
[TBL] [Abstract][Full Text] [Related]
6. Suxamethonium in myasthenia gravis.
Wainwright AP; Brodrick PM
Anaesthesia; 1987 Sep; 42(9):950-7. PubMed ID: 3674355
[TBL] [Abstract][Full Text] [Related]
7. Suxamethonium-neostigmine interaction in patients with normal or atypical cholinesterase.
Baraka A
Br J Anaesth; 1977 May; 49(5):479-84. PubMed ID: 861116
[TBL] [Abstract][Full Text] [Related]
8. The effect of bambuterol on plasma cholinesterase activity and suxamethonium-induced neuromuscular blockade in subjects heterozygous for abnormal plasma cholinesterase.
Bang U; Viby-Mogensen J; Wirén JE
Acta Anaesthesiol Scand; 1990 Oct; 34(7):600-4. PubMed ID: 2244450
[TBL] [Abstract][Full Text] [Related]
9. Response to suxamethonium during propofol-fentanyl-N2O/O2 anaesthesia in a patient with active myasthenia gravis receiving long-term anticholinesterase therapy.
Vanlinthout LE; Robertson EN; Booij LH
Anaesthesia; 1994 Jun; 49(6):509-11. PubMed ID: 8017595
[TBL] [Abstract][Full Text] [Related]
10. Pseudocholinesterase activity and atracurium v. suxamethonium block.
Baraka A; Wakid N; Noueihed R; Karam H; Bolotova N
Br J Anaesth; 1986; 58 Suppl 1():91S-95S. PubMed ID: 3011044
[TBL] [Abstract][Full Text] [Related]
11. Plasma concentration of pyridostigmine and effects in myastenia gravis.
Chan K; Calvey TN
Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):596-601. PubMed ID: 199393
[TBL] [Abstract][Full Text] [Related]
12. Neuromuscular blocking action of suxamethonium after antagonism of vecuronium by edrophonium, pyridostigmine or neostigmine.
Fleming NW; Macres S; Antognini JF; Vengco J
Br J Anaesth; 1996 Oct; 77(4):492-5. PubMed ID: 8942334
[TBL] [Abstract][Full Text] [Related]
13. Hexafluorenium-suxamethonium interaction in patients with normal versus atypical cholinesterase.
Baraka A
Br J Anaesth; 1975 Aug; 47(8):885-8. PubMed ID: 1201167
[TBL] [Abstract][Full Text] [Related]
14. The effect of bambuterol (carbamylated terbutaline) on plasma cholinesterase activity and suxamethonium-induced neuromuscular blockade in genotypically normal patients.
Bang U; Viby-Mogensen J; Wirén JE; Skovgaard LT
Acta Anaesthesiol Scand; 1990 Oct; 34(7):596-9. PubMed ID: 2244449
[TBL] [Abstract][Full Text] [Related]
15. The relationship between the level of cholinesterase in plasma and the action of suxamethonium in animals.
Hobbiger F; Peck AW
Br J Pharmacol; 1970 Dec; 40(4):775-89. PubMed ID: 4322043
[TBL] [Abstract][Full Text] [Related]
16. Neuromuscular response to succinylcholine-vecuronium sequence in three myasthenic patients undergoing thymectomy.
Baraka A; Tabboush Z
Anesth Analg; 1991 Jun; 72(6):827-30. PubMed ID: 1674649
[No Abstract] [Full Text] [Related]
17. Cisatracurium in a myasthenic patient undergoing thymectomy.
Baraka A; Siddik S; Kawkabani N
Can J Anaesth; 1999 Aug; 46(8):779-82. PubMed ID: 10451139
[TBL] [Abstract][Full Text] [Related]
18. Reaction to succinylcholine in two patients segregating for the plasma cholinesterase allele Ek.
Jensen FS; Viby-Mogensen J
Acta Anaesthesiol Scand; 1992 Nov; 36(8):753-7. PubMed ID: 1334612
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the enzymic degradation of suxamethonium and mivacurium increases the onset time of submaximal neuromuscular block.
Beaufort TM; Nigrovic V; Proost JH; Houwertjes MC; Wierda JM
Anesthesiology; 1998 Sep; 89(3):707-14. PubMed ID: 9743409
[TBL] [Abstract][Full Text] [Related]
20. Suxamethonium and myasthenia gravis.
Richardson J
Anaesthesia; 1988 Feb; 43(2):161. PubMed ID: 3354818
[No Abstract] [Full Text] [Related]
[Next] [New Search]
